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Objectives: The sudden emergence of dengue virus type 1 (DENV-1) and its co-circulation with
predominant DENV-3 was the hallmark of the 2006 dengue fever outbreak in Delhi. Viruses that
circulated between 1996 and 2005 in the City have been well characterized, but the genomic
diversity in 2006 strains is not known. The present study was undertaken to reveal the emerging
molecular genotype(s) and evolutionary trend of the viruses responsible for the dengue fever
outbreak in Delhi during 2006.
Study design: The CprM gene junction of the DENV isolates from the 2006 Delhi dengue fever
outbreak were subjected to nucleotide sequencing. Comparative phylogenetic analysis was done
using DENV-1 and DENV-3 sequences retrieved from the global database.
Results: Multiple sequence alignment revealed only substitutions, with no insertions or deletions.
A dendrogram indicated emergence of a distinct lineage of DENV-1 (having similarity with the
Comoros/Singapore 1993 and Delhi 1982 strains, but quite different from the Delhi 2005 lineage)
and microevolution of the pre-circulating DENV-3. These findings point towards the circulation of
two independent lineages of DENV-1 in Delhi during 2005 and 2006.
Conclusions: It is feared that the introduction of an independent lineage of the outbreak-
associated strain of DENV-1 and its co-circulation with the deeply-rooted strain of DENV-3 in
Delhi may result in yet another, possibly more severe outbreak in the near future.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.§ Our research findings related to DENV-3 were presented in part at the 23rd Annual Clinical Virology Symposium, 29 April—2 May 2007,
Clearwater Beach, Florida, USA.
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The more frequent outbreaks of dengue than ever before in
several parts of Southeast Asia and subtropical countries have
led to serious public health concerns in recent years.1,2 The
situation in India during the past decade has worsened.3—6
Dengue virus (DENV) infection generally causes a mild febrile
illness, referred to as dengue fever (DF), but some may lead
to severe life-threatening disease — dengue hemorrhagic
fever (DHF) or dengue shock syndrome (DSS). As per World
Health Organization (WHO) estimates, over 50 million cases
are reported worldwide, of which 500 000 may develop DHF/
DSS. Rapid urbanization, the increase in human and vector
populations, and expanded travel have offered added oppor-
tunities for the spread of the virus across countries and
continents.7—9
There are four antigenically related, but genetically dis-
tinct serotypes (DENV-1 to -4), each of which contains a
phylogenetically distinct cluster of viruses referred to as
‘genotypes’ or ‘subtypes’.10—13 These genotypes are often
linked to specific geographical areas. The disease severity
can be associated with a particular genotype or due to
sequential infection of heterotypic virus.14—18 Although gen-
otyping is performed on the basis of different gene regions,
CprM gene-based genotyping has been most widely used on
Indian dengue isolates. A new set of consensus primers (D1
and D2) was first designed and developed by Lanciotti et al. in
1992,19 which was capable of amplifying a 511 bp region of
the CprM gene of all four types of dengue virus. Subsequently,
the usefulness of this CprM gene region for carrying out
subtyping of dengue viruses has been established by us and
other researchers.4,5,20,21
Although several parts of India are endemic for dengue,
Delhi has been worst hit during the past decade, the Delhi DF
outbreaks of 2003 and 2006 being the most recent ones.4,6 On
record, all the four known serotypes ofDENVhavecirculated in
India at different times,22 but generally one serotype dom-
inates during a given outbreak. The first major DF outbreak in
Delhi in 1996 was caused by DENV-2 genotype IV,3 and the virus
remained in circulation in and around Delhi until the end of
2002.5 In 2003 however, we noticed DENV-3 as the leading
cause of a major DF outbreak in the region,6 and DENV-2 had
been virtually replaced. This DENV-3 remained in dominant
circulation until the 2006 Delhi DF outbreak, but approxi-
mately 30% of cases during 2006 were also found to be due
to newly emerging DENV-1. It has been observed that a newly
emerging serotype/genotype can appear suddenly and co-
circulate along with the existing genotype for some time
before replacing the latter in subsequent years. In view of
the frequent rise and fall of the different genotype(s) of
dengue viruses noticed in recent years, the present study
was designed to carry out CprM sequence-based molecular
subtyping and decipher the evolutionary trend of the two
viruses (DENV-1 and DENV-3) that co-circulated during the
2006 DF outbreak in Delhi.
Materials and methods
Clinical samples
One hundred and seventy-nine acute phase serum samples
from clinically suspected cases of dengue were collectedfrom different geographical locations of Delhi during the
peak phase (October) of the 2006 Delhi DF outbreak.
Informed consent from the patients was obtained after
explaining the nature and possible consequences of the
study. Approval of the Institute’s ethics committee was also
given to carry out the study. Samples were transported to the
laboratory with the due precautions recommended for hand-
ling RNA viruses.
cDNA synthesis and amplification of target CprM
gene junction
Viral RNAwasextracted from140 ml of serumsamples using the
QIAamp Ultrasens virus kit (Qiagen, Germany) following the
manufacturer’s protocol. The final elutionwas done in 50 ml of
diethyl pyrocarbonate (DEPC)-treated water before storing at
70 8C until use. The reverse transcriptase-polymerase chain
reaction (RT-PCR) was carried out as previously described by
us6 usingCprMgene-specificprimers (D1andD2) thatamplified
the 511 bp amplicon reported by Lanciotti et al. in 1992.19
cDNAwas synthesized in a 10 ml reaction volumewith a reverse
transcriptase (RT) mix comprising 5 RT buffer, 10 mM dNTPs,
100 mM DTT, 20 U RNase inhibitor, and 50 U of MultiScribe RT
(ABI, USA) with reverse primer (D2: 50-TTGCACCAACAGT-
CAATGTCTTCAGGTTC-30). The RT mix was incubated at
42 8C for 20 min followed by 99 8C for 5 min for inactivation
ofMultiScribeRT.Amplificationof thecDNAwas carriedout ina
50 ml reaction volume with PCR mix containing 1 RT-PCR
buffer, 1.75 mM MgCl2, 0.8 mM dNTPs, 2.5 U AmpliTaq Gold
DNA polymerase (ABI, USA) using forward primer (D1: 50-
TCAATATGCTGAAACGCGCGAGAAACCG-30), in a PCR thermal
cycler (ABI 9700). Thermalprofile included initialdenaturation
at 95 8C for 10 min followed by 35 cycles of denaturation at
95 8C for 30 s, annealing at 55 8C for 30 s, extension at 72 8C for
1 min, and final extension at 72 8C for 10 min. The PCR pro-
ducts were gel-purified from 1.2% agarose gel using Accu-Prep
gel extraction kit (Bioneer, USA).
Automated nucleotide sequencing
Purified amplicons were subjected to automated nucleotide
sequencing with both forward and reverse primers separately.
Sequencing was carried-out using the Big Dye terminator kit
(ABI, USA). Approximately 25 ng of purified PCR product was
mixed with 3.2 pM respective primer (D1/D2) and a reaction
mixture containing AmpliTaq DNA polymerase and four dye-
labeled dideoxynucleotide terminators. The reaction mixture
was placed onto a preheated thermal cycler. Cycle sequencing
parameters included 25 cycles at 96 8C for 10 s, 50 8C for 5 s,
and 60 8C for 4 min. The reaction mixture was purified by
precipitation with 3 M sodium acetate (pH 4.6) and 75% iso-
propanol, and the extension product was vacuum dried. The
DNA pellet was resuspended in 10 ml of template suppression
reagent (TSR), heated at 95 8C for 2 min and immediately
chilled on ice, mixed and after brief spin, finally loaded onto
the ABI 310 genetic analyzer (ABI, USA).
Sequence alignments and phylogenetic analysis
CprM gene sequences obtained in the present study were
submitted to GenBank at www.ncbi.nlm.nih.gov (accession
Table 1 Details of patients and DENV-3 and DENV-1 isolates sequenced in this study
Patient ID Age/sex Clinical diagnosisa, b ID of isolated virus GenBank accession No. Serotype
D-201 33/M DF 01den06 EF080812 DENV-3
D-203 25/M DF 02den06 EF080813 DENV-3
D-81 40/F DF 03/3/del2006 EF126994 DENV-3
D-82 19/F DF 04/3/del2006 EF126995 DENV-3
D-212 10/M DF 05/3/del2006 EF126996 DENV-3
D-166 29/F DHF (grade II) 06/3/del2006 EF126997 DENV-3
D-179 15/F DF INDI06DEN07 EF546768 DENV-3
D-224 30/M DF INDI06DEN08 EF546769 DENV-3
D-178 5/M DF INDI06DEN09 EF546770 DENV-3
D-232 23/M DF INDI06DEN10 EF546771 DENV-3
D-217 15/M DF INDI06DEN11 EF546772 DENV-3
D-168 50/F DHF (grade II) INDI06DEN12 EF546773 DENV-3
D-119 25/M DF INDI06DEN13 EF546774 DENV-3
D-85 22/F DF INDI06DEN14 EF546775 DENV-3
D-162 16/M DHF (grade II) 01den06 EF080814 DENV-1
D-74 18/M DF 02den06 EF080815 DENV-1
D-181 31/M DF 03/1/del2006 EF126998 DENV-1
D-161 15/F DHF (grade III) 04/1/del2006 EF126999 DENV-1
D-77 27/F DF 05/1/del2006 EF127000 DENV-1
D-78 34/F DF 06/1/del2006 EF127001 DENV-1
a All cases belonged to Delhi.
b The majority of the cases presented with clinical symptoms such as headache (80%), myalgia (74%), rash (53%), vomiting (39%), epistaxis
(15%), melena (4%), and fever ranging from 39 to 40 8C.
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to confirm the identity of strains. For comparison, we
retrieved 50 DENV-1 and 43 DENV-3 CprM sequences belong-
ing to diverse geographical locations from the global data-
base, as shown in the phylogenetic trees in Figures 1 and 2,
respectively. The DNAStar software package was used to
examine the percent identity and diversity among
sequences. Phylogenetic analysis was done using MEGA ver-
sion 3.1,23 and the evolutionary tree was constructed using
the neighbor-joining method24 with a bootstrap value of 1000
replicates.
Results
RT-PCR and nucleotide sequencing revealed that 20 samples
were positive for the presence of dengue virus-specific
nucleic acid. The BLAST search of these 20 CprM gene
sequences confirmed 14 cases as DENV-3 and six as DENV-
1. While DENV-3 sequences were closely related to the Delhi
strains of 2003—05 and Guatemala strains isolated in 1998,
the DENV-1 sequences were found to be similar to the
Comoros/Singapore 1993 strains and the Delhi 1982 strain.
Multiple sequence alignment of the 14 DENV-3 and six DENV-1
sequences of this study indicated substitutions that spanned
the whole sequence, and no insertions or deletions were
identified.
For comparative phylogenetic analysis of DENV-1, we
selected a CprM gene interval of 354 nucleotides (nucleotides
208 to 561) of DENV-1 from the previously reported global
sequences. On sequence analysis it was observed that the
2006 Delhi DENV-1 CprM sequences showed sequence simi-
larity of 98.6—97.7% (mean 98.15%) and 97.2—97.7% (mean
97.45%), respectively, with the 1993 sequences from Singa-
pore and Comoros. On comparison with other Indiansequences from Delhi sampled in 1982 and 1970 (closely
related to outbreak-associated strains from Myanmar), we
observed sequence similarity of 97.7—98% (mean 97.75%) and
95.8—96.3% (mean 96.05%), respectively. Three nucleotide
changes (all transitions) were found in common in the
2006 Delhi DENV-1 sequences, 1993 Singapore/Comoros
sequences, and 1982 Delhi sequences: T!C transitions were
observed at nucleotide positions 208 and 532, and a G!A
transition at nucleotide position 550. However, in 2005 DENV-
1 sequences from Delhi, three changes were in common with
strains from South America (Brazil, Argentina, and Paraguay)
viz. T!C at nucleotide position 244, C!T at position 253,
and A!G at position 388. Two nucleotide changes (C!T at
position 469 and T!G at position 520) were found exclusively
in 2006 DENV-1 sequences from Delhi. Sequence divergence
of 3.1% and 4.8% was observed when 2006 Delhi sequences
were compared with 2005 Delhi sequences and 1962—64
Vellore (South India) sequences, respectively. The DENV-1
Delhi sequences of 2006 of this study also showed a sequence
divergence of 0.8% among themselves. Comparison with
reference sequences revealed that only transition mutations
occurred in 2006 Indian (Delhi) DENV-1 sequences, which
were mostly synonymous in nature. Non-synonymous muta-
tions were observed amongst 2006 Delhi isolates 01den06 and
03/1/del2006, where isoleucine was replaced by threonine
(amino acid position 59), and in 02den06 and 04/1/del2006
where leucine was replaced by serine (amino acid position
155).
A phylogenetic tree generated on the basis of the
sequences of the present study and previously reported
DENV-1 CprM sequences revealed clustering of isolates from
different countries in three distinct genotypes (genotypes I,
II, and III) (Figure 1). However, it is noteworthy that all Indian
DENV-1 sequences (from this study and those reported by
Figure 1 DENV-1 phylogenetic tree. The tree was generated by the neighbor-joining method based on 354 bp nucleotide sequences
of CprM gene region. Each strain is denoted by country of isolation and last two digits of year of isolation, followed by virus ID. Bootstrap
support values (>50%) are shown formajor nodes on the tree. All horizontal branch lengths are drawn to scale. DENV-1 sequences of the
present study are denoted in bold.
Emergence of an independent lineage of DENV-1 545other workers) belonging to different outbreaks, clustered in
genotype III in close proximity with the viruses from South
America, Myanmar, Africa, and Singapore, indicating circula-
tion of DENV-1 genotype III in India. Although, within geno-
type III, six DENV-1 isolates of the present study clustered as a
distinct subclade, these were found to be closely related to
1993 isolates sampled from Comoros and Singapore and 1982
isolate sampled from Delhi, India. However, based on the
supportive bootstrap value (Figure 1), it is evident that a new
lineage of DENV-1 in Delhi has evolved recently. It was
observed that these six DENV-1 strains of 2006 were also
related to 1970 Delhi strain and outbreak-associated Myan-
mar strains of 1971, 1976, 1996, and 1998. Indian isolates of
2005 sampled in Delhi (del/05/1474/D1, del/05/902/D1)
clustered with DENV-1 strains from the Americas, exhibitingclose proximity with American lineage. Segregation of Delhi
2005 and 2006 isolates into two different groups in the
phylogenetic tree (Figure 1) revealed that there was inde-
pendent existence of two distinct lineages of DENV-1 in this
part of the country. Three DENV-1 strains that circulated in
the southern part of India during 1962—64 (631286/1963/
Vellore, 623996/Vellore, and 64411/1964/vellore) clustered
separately (third lineage) from other Indian strains. Three
distinct lineages of Indian DENV-1 genotype III (1962—64
Vellore lineage and Delhi 2005 and 2006 lineages) are evident
from the phylogenetic tree (Figure 1). However, whether the
existence of Vellore (South India) lineage still exists cannot
be confirmed because of the non-availability of south Indian
sequences of recent years. Genotype II was more cosmopo-
litan, with viruses from Hawaii, Indonesia, China, Yap State,
Figure 2 DENV-3 phylogenetic tree. The tree was generated by the neighbor-joining method based on 434 bp nucleotide sequences
of CprM gene region. Each strain is denoted by country of isolation and last two digits of year of isolation, followed by virus ID. Bootstrap
support values (>50%) are shown for major nodes on the tree. All horizontal branch lengths are drawn to scale. DENV-3 sequences of the
present study are denoted in bold.
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from Southeast Asia, particularly Thailand and China.
Depending on the availability of global DENV-3 sequences
for comparison in the database, a 433 bp region (nucleotides
180—612) of the DENV-3 CprM gene junction was selected for
phylogenetic analysis. When DENV-3 CprM sequences were
analyzed, it was observed that 2006 Delhi sequences were
closely related to sequences from Guatemala (1998) and pre-
sented a nucleotide identity of 95.9—98.2% (mean 97.05%).
On comparison of Delhi 2006 sequences with other Indian
sequences from years 2003, 2004, and 2005, mean sequence
divergence of 2.85%, 2.15%, and 1.6%, respectively, were
observed. Common amino acid mutations observed in 2006
DENV-3 sequences were isoleucine!valine (amino acid posi-
tion 88) and aspartate!asparagine (amino acid position 121) in
04/3/del2006 and 06/3/del2006; isoleucine!phenylalanine(amino acid position 127), glycine!glutamate (amino acid
position 122), and arginine!lysine (amino acid position 55)
in 04/3/del2006 and 05/3/del2006; and valine!glycine
(amino acid position 128) in INDI06DEN08, INDI06DEN10, and
INDI06DEN12.
A phylogenetic tree constructed on the basis of DENV-3
sequences from different parts of the world segregated into
three genotypes (Figure 2). Fourteen DENV-3 strains of the
present study clustered within genotype III of DENV-3 along
with the previously reported Indian and global sequences
from the Caribbean, Americas, Africa, and Sri Lanka. Our
2006 Delhi DENV-3 sequences were closely related to Gua-
temala strain (GUATE98-5). Genotype II comprised viruses
fromMalaysia and Thailand isolated in 1994 and 1998, respec-
tively. Three DENV-3 strains (Philippines 56 H87, Indonesia
98902890 DF DV-3, and Philippines PhMH-J1-97) clustered
Emergence of an independent lineage of DENV-1 547together to form genotype I. Due to non-availability of the
DENV-3 genotype IV CprM global sequences, we could not
include these while constructing the phylogenetic tree.
Discussion
India is endemic for dengue having witnessed several DF/DHF
outbreaks in the last decade.3,4,6,25 The last major DF out-
break in India occurred between September and October
2006 involving more than 12 000 cases and nearly 184 deaths,
of which approximately 3366 cases and 65 deaths were
reported from Delhi alone.26 Molecular characterization of
the viruses implicated in this outbreak was deemed necessary
with the view to: (1) identify molecular subtype/genotype of
the dengue virus, (2) determine the introduction of new or
evolving lineages, if any, and (3) elucidate the changing
pattern of molecular epidemiology of dengue viruses in this
part of India.
Particular genotypes are associated with disease severity
and changes in the prevalent type may also lead to increased
severity of the outbreak. In our study, an interesting pattern
of emergence and circulation of dengue viruses in Delhi has
come to light. From 1996, DENV-2 genotype IV was circulating
in Delhi3 when DENV-3 in co-circulation with DENV-2 emerged
in 2003,6 replacing DENV-2 in subsequent years. During the
present study on the 2006 Delhi DF outbreak samples, we
observed emergence and co-circulation of DENV-1 with pre-
dominance of DENV-3, thereby increasing the risk of severity
of the disease in a population already exposed to a previous
serotype. Such study of epidemiological dynamics in popula-
tions in which more than one DENV serotype co-circulate
simultaneously is of special significance.27 If the trend
observed in our present study continues, the probability of
dominant emergence of DENV-1 (suppressing the pre-existing
DENV-3) in coming years cannot be ruled out. Emergence of a
new virus serotype is mostly associated with severe disease
outbreaks, thereby making the situation more alarming.
CprM gene-based RT-PCR using the specific primer set
evaluated by Lanciotti et al. in 1992 and Harris et al. in
199819,28 has the potential to identify all four dengue virus
serotypes. In addition, studies suggest that CprM gene
sequences also produce epidemiologically valuable informa-
tion. The usefulness of the CprM gene junction for molecular
epidemiology of DENV-2 and DENV-3 strains has been estab-
lished time and again by us and other researchers.4,5,20,21 We
have studied the sequence of these dengue viruses directly
from the patient sera as has also been supported by other
researchers.5,16
Analysis of translated amino acid sequences revealed
changes in our DENV-3 isolates, INDI06DEN08, INDI06DEN10,
and INDI06DEN12where non-polar valine was replaced by non-
polar glycine, hence no significant change. In addition, in
amino acid changes in 04/3/del2006, 06/3/del2006 (isoleuci-
ne!valine and aspartate!asparagine) and 04/3/del2006,
05/3/del2006 (isoleucine!phenylalanine and argini-
ne!lysine), no significant changes were observed in hydro-
pathy index.29 However, in DENV-1 2006 Delhi isolates 01den06
and 03/1/del2006, where polar isoleucine was replaced by
non-polar threonine, and again in 02den06 and 04/1/del2006,
where polar leucine was replaced by non-polar serine,
the implications in terms of disease severity could not be
established.Five different genotypes of DENV-1 and four genotypes of
DENV-3 have been proposed.13,25,30 On analysis of CprM
sequencesofDENV-1 (354 bp)andDENV-3 (433 bp)ofour study,
we observed the presence of three genotypes each in DENV-1
and DENV-3. Phylogenetic analysis revealed that 2006 DENV-3
strains of this study were closely related to the strains that
circulated in Delhi between 2003 and 2005,whichwere similar
to strains from Guatemala.6,31 In the case of DENV-1, we
observed clustering of sequences below the genotype level
that correlated with the geographical origin and/or time of
isolation, which appears to represent distinct lineages. Inter-
estingly, the data retrieved from NCBI GenBank revealed the
existence of a different lineage of DENV-1 in South India
(Vellore) during 1962—64 (accession numbers AY593212 and
AY593211) andanother lineage inDelhiduring2005 (accession
numbers EF064776 and EF064774). However, all the six
DENV-1 strains of 2006 in the present study may have evolved
from Delhi 1982 or Singapore/Comoros 1993 strains.
The dendrogram suggests that Delhi had at least two
different lineages of DENV-1 emerging independently during
two consecutive years (2005 and 2006), 2005 strains cluster-
ing with American lineage, while 2006 strains forming a
distinct lineage, but clustering with the Indian (1982), Afri-
can (Comoros), and Southeast Asian (Singapore) strains.
Based on E gene sequences, Domingo et al.32 also reported
the presence of two new lineages of Indian DENV-1 strains
belonging to years 2001—2005. Given the geographical or
temporal association among sequences belonging to the same
lineage, a classification based on lineages facilitates surveil-
lance and the tracking-down of the origin of dengue virus
isolates.32
The inadequate availability of Indian sequence data for
the past years from homologous gene region has been a
limiting factor that prevents researchers from interpreting
information on phylogeny of these viruses. In our study,
DENV-1 strain (S275/90) sampled in Singapore in 1990
grouped in genotype I. However, this strain was classified
as genotype III on the basis of full-length E gene sequences,25
where it clustered with strains from the Americas, Africa,
and Southeast Asia. Domingo et al.32 found this strain to be a
product of a recombination event with parents from differ-
ent lineages. This strain is a recombinant between American
and Asian lineage. Such recombinations may be revealed at
times when phylogenetic trees are drawn on the basis of
different genes, thereby explaining the reason for ambiguity
in results.
The dendrogram and increase in divergence of DENV-3
sequences each year (Figure 2) suggests that these viruses
have undergone microevolution, as is evident from the
temporal structure of the distinct clade of these viruses,
and that they have been constantly evolving each year since
its emergence in 2003, although the stochastic or selective
pressure on this virus has not been studied. A DENV-3-asso-
ciated outbreak was last reported in India in 1994.33 How-
ever, DENV-3 was reported to be the etiologic agent of the
firstmajor DHF outbreak in neighboring Bangladesh in 200134
and was also implicated in outbreaks in Sri Lanka in the
recent past.35,36 Furthermore, there was no indication of
either serotype confirming association of any particular
variant with serious dengue disease, as the viruses isolated
from DHF patients fell at different locations on the phylo-
genetic tree. No significant correlation was seen between
548 H. Kukreti et al.the CprM sequences and the differential clinical severity,
confirming the absence of any known virulencemarker in this
region.
It is possible that the emergence of an outbreak-asso-
ciated strain/lineage of DENV-1 along with the pre-existing
DENV-3 in Delhi may result in another major DF/DHF outbreak
in the near future. The changing epidemiology of dengue
virus infection in Delhi is a cause of concern, more so because
the emergence of a newer genotype and/or lineage may
hamper timely forecasting of the probable serotype/geno-
type of the virus. Findings of any such study will be useful if
an early warning signal on the emerging genotypes (particu-
larly DHF-causing strains) is conveyed to the public health
authorities before or during the early phase of the outbreak,
so that the recommended control measures are implemented
stringently and in time.
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